Tempus AI Change in Inventories 2023-2025 | TEM

Tempus AI annual/quarterly change in inventories history and growth rate from 2023 to 2025. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
  • Tempus AI change in inventories for the quarter ending June 30, 2025 was $0.002B, a 151.34% decline year-over-year.
  • Tempus AI change in inventories for the twelve months ending June 30, 2025 was $-0.016B, a 4.8% decline year-over-year.
  • Tempus AI annual change in inventories for 2024 was $-0.01B, a 45.38% increase from 2023.
  • Tempus AI annual change in inventories for 2023 was $-0.007B, a 400.23% increase from 2022.
  • Tempus AI annual change in inventories for 2022 was $-0.001B, a 0% decline from .
Tempus AI Annual Change in Inventories
(Millions of US $)
2024 $-10
2023 $-7
2022 $-1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $13.989B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.530B 60.47
Doximity (DOCS) United States $12.688B 56.45
Hims & Hers Health (HIMS) United States $10.074B 82.54
IRhythm Technologies (IRTC) United States $5.433B 0.00
Hinge Health (HNGE) United States $4.491B 0.00
Inspire Medical Systems (INSP) United States $2.839B 41.73
Privia Health (PRVA) United States $2.699B 199.91
Heartflow (HTFL) $2.367B 0.00
Enovis (ENOV) United States $1.797B 9.50
10x Genomics (TXG) United States $1.780B 0.00
Phreesia (PHR) United States $1.770B 0.00
Omnicell (OMCL) United States $1.544B 29.75
Schrodinger (SDGR) United States $1.495B 0.00
Azenta (AZTA) United States $1.446B 63.10
Clover Health Investments (CLOV) United States $1.399B 0.00
Claritev (CTEV) United States $1.189B 0.00
Evolent Health (EVH) United States $1.127B 0.00
Fulgent Genetics (FLGT) United States $0.666B 0.00
Zepp Health (ZEPP) Netherlands $0.580B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.485B 0.00
Talkspace (TALK) United States $0.469B 140.00
Butterfly Network (BFLY) United States $0.383B 0.00
Carlsmed (CARL) United States $0.346B 0.00
TruBridge (TBRG) United States $0.307B 53.89
Outset Medical (OM) United States $0.252B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.244B 0.00
Health Catalyst (HCAT) United States $0.231B 0.00
Nyxoah SA (NYXH) Belgium $0.219B 0.00
KORU Medical Systems (KRMD) United States $0.203B 0.00
CapsoVision (CV) United States $0.187B 0.00
MDxHealth SA (MDXH) Belgium $0.156B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.148B 0.00
CareCloud (CCLD) United States $0.120B 5.44
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.074B 0.00
Pulmonx (LUNG) United States $0.069B 0.00
111 (YI) China $0.060B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Precipio (PRPO) United States $0.023B 0.00
Zhongchao (ZCMD) China $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.017B 0.00
PROFUSA (PFSA) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.005B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00